Auburndale, MA, United States of America

Shannon G Contrastano

USPTO Granted Patents = 4 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Shannon G Contrastano

Introduction

Shannon G Contrastano is an accomplished inventor based in Auburndale, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 4 patents to his name, Contrastano is recognized for his work in creating compositions that enhance the efficacy of cancer therapies.

Latest Patents

One of his latest patents focuses on "Compositions for treating cancer." This patent provides compositions and methods that comprise recombinant particles suitable for specifically delivering one or more chimeric antigen receptors to immune effector cells in vivo. Another notable patent is related to "Antigen binding polypeptides." This disclosure provides compositions that include antigen binding polypeptides, particularly those comprising antibodies or antigen binding fragments, nucleic acids encoding the polypeptides, and vectors for expressing the same.

Career Highlights

Shannon G Contrastano is currently associated with Kelonia Therapeutics, Inc., where he continues to push the boundaries of cancer treatment through innovative research. His work has garnered attention in the scientific community, contributing to advancements in therapeutic strategies.

Collaborations

Some of his notable coworkers include Kevin M Friedman and Molly R Perkins, who collaborate with him on various projects aimed at improving cancer therapies.

Conclusion

Shannon G Contrastano's contributions to the field of cancer treatment through his patents and collaborations highlight his commitment to innovation and research. His work continues to pave the way for new therapeutic approaches in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…